5 Revealing Analyst Questions From Unum Group's Q2 Earnings Call

Unum Group’s second quarter was marked by higher-than-expected claims costs and weaker investment income, leading to a significant miss on non-GAAP profit expectations despite solid revenue growth. CEO Rick McKenney described the quarter as one where "results fell short of our expectations, particularly in GAAP earnings," attributing the underperformance mainly to elevated claims in group products and the Closed Block. Management also cited persistency and steady premium growth across most lines as offsetting some of the margin pressure, but acknowledged that sales momentum remained slower than anticipated.

Is now the time to buy UNM? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Unum Group’s Q2 Earnings Call

• Michael Augustus Ward (UBS) asked about drivers of elevated group disability claims and whether the trend would persist; CFO Steven Zabel explained higher claim sizes and stable recoveries, projecting consistent benefit ratios for the remainder of the year.
• John Bakewell Barnidge (Piper Sandler) questioned the sustainability of free cash flow and rationale for not increasing buybacks further; CEO Rick McKenney stated capital deployment is balanced with the need for flexibility and a sustainable approach.
• Elyse Beth Greenspan (Wells Fargo) inquired about the outlook for disability benefit ratios and long-term care exposure; Zabel and McKenney affirmed current levels are sustainable, but ongoing review is needed for further LTC derisking.
• Ryan Joel Krueger (KBW) sought color on persistency trends and competitive pressures; management credited digital integration and product value for strong renewal rates but noted that incumbent carriers benefit in the current environment.
• Taylor Alexander Scott (Barclays) asked about progress on LTC premium rate approvals and potential medical cost inflation; Zabel reported 60% achievement on rate increases and said medical inflation has minimal direct impact on Unum’s results.

Catalysts in Upcoming Quarters

In the coming quarters, our team will monitor (1) whether group claims experience stabilizes, supporting margin recovery; (2) progress on further LTC risk transfer transactions and their impact on capital flexibility; and (3) the extent to which digital initiatives like HR Connect continue to drive persistency and offset sluggish sales. Persistent investment income trends and the pace of premium growth in international and voluntary benefits will also be crucial signposts.

Unum Group currently trades at $70.34, down from $80.96 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.